Patrick_and_the_ricks said:
Pretty sure we can cure Aids too, but a one time cure doesn't make anywhere as much cash as lifetime treatments.
AS: just picking up your quote, the "you" in my responce is general, not necessarily.. you
Actually, curing 30m people + everyone who keeps getting infected, and getting 100% marketshare because you're the only one with a cure -- that's VERY profitable. That anticorporate stance of "they don't want to cure, because there's more money in treating" is a very ...naive, and doesn't even come close to the realities of pharmaceutical research.
Treating symptoms is something that can be progressively done as our understanding of diseases increases; finding a lasting cure from an imprefect understanding of a disease is much harder.
That counts double for retroviral diseases (HIV, Hep B), where the virus genome is integrated into your own. Even if we could methylate specific genes to deactivate them (and we really can't, and although we're able to detect DNA methylation, that's fairly recent), there's a whole baggage of legal & ethical questions left unanswered, before you start playing around with the genome of living people.
If there's one thing we know better now that we did 15 years ago, then it's that there are no easy answers. If there were, Huntingtons disease would be one of the first to go.
Don't mistake what you learned in highschool (which corresponds to the state of the art knowledge of 30-40 years ago) with actual scientific knowledge please.
--
As to the article in question: it has been written by someone with either little knowledge of what he's talking about, or little knowledge in the unbiased reporting of actual news items.
DCA shows some promise in reversing abnormal growth of cells, and re-enabling programmed cell death. So far, so good.
It also causes liver cancer in rats, is toxic, and DCA treatements against lactic acidemia may have led to improvements of the condition, but didn't actually cure people, or had to be interrupted due to toxicity.
DCA is entering the next phase of trials, mostly because stage 2 trails have shown some promise. It's not a wonder drug however: It's another possible step in treating tumors - that's far removed from being a magical cure for cancer.
The Moehlinator said:
Sad, isn't it? My girlfriend had to go to the ER a while back and she was prescribed 3 or 4 big name drugs (variations of oxycodone and the like). When we went to the pharmacy to pick them up, the tab was over $400 for three weeks worth of pills. Fortunately for me, my uncle is a doctor and took a look at the list of drugs. He rewrote the prescriptions for the generic versions of the drug (same exact drug down to the molecular lvl, just no fancy stamping on the pill) and we picked up everything for under $14. At that point, I lost the tiny tiny shred of hope I had left for modern western medicine.
How so? A company dumps tons of money into research & getting a drug to market; they get to profit from it exclusively for a number of years, and afterwards everyone who can duplicate the process may do so & bring their generic imitation drugs to the market for a lot cheaper.
Seems to me like a system that, while not perfect for early adopters (adopters.... sorry for that word, it's not like they have a choice), ensures researching companies stay in business and keep looking for new drugs, and that a decade down the line, the drug becomes cheap.
Making money by improving quality of life - i understand some people see that as ethically disgusting, but i just can't bend my brain into thinking that someone who gets treated for a disease of off worse than someone who isn't.